Google Real-Estate Ad Test Sends Zillow Tumbling

Google real-estate ad test put homes-for-sale at the top of mobile Search, coinciding with a Zillow stock plunge and pressuring portal leads.

December 15, 2025·2 min read
View all news articles
Flat filled vector of a mobile house-listing tile fused with a search server, symbolizing the Google real-estate ad test.

KEY TAKEAWAYS

  • Google tested a mobile ad unit that put homes-for-sale at the top of Search results.
  • The experiment was a paid partnership with ComeHome and HouseCanary, not an organic Search placement.
  • Reports linked the test to sector selling that hit Zillow hardest among portals.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Google’s real‑estate ad test placed homes‑for‑sale listings at the top of mobile Search results, and on Dec. 15, 2025, reports of the limited Google‑ComeHome experiment coincided with a sharp drop in online‑real‑estate stocks led by Zillow Group, Inc. (Z).

Google’s Mobile Listings Test and ComeHome Partnership

On Dec. 12, 2025, industry analyst Mike DelPrete published screenshots documenting a limited mobile test that integrates for‑sale property listings directly into Google Search results. The test is framed as an experiment rather than organic search results.

The mobile unit displays a carousel of about 25 listings with a “show more” function to load additional properties. Each entry links to a full property‑detail page and includes agent contact information plus buttons to request a tour or contact an agent, mirroring lead‑generation features typical of real‑estate portals.

A disclaimer on the unit identifies the display as a curated, paid partnership between Google and ComeHome, the nationwide brokerage and portal brand operated by HouseCanary, Inc., an AI‑driven real‑estate analytics and brokerage company. DelPrete described the test as significant, saying, “Google putting for sale listings directly into search results — even if it’s a test — is a big deal.”

Zillow Stock Decline and Market Response

On Dec. 15, 2025, market reports linked the Google mobile listings experiment to sector selling in online‑real‑estate shares, with Zillow suffering the largest percentage decline among portals that day.

No new formal guidance or relevant SEC filings from Zillow or Alphabet addressing the listings test appeared in the 72 hours following the reports. Searches of U.S. regulatory databases found no antitrust notifications related to the ad test.

Some sell‑side analysts described the immediate stock reaction as disproportionate given the experiment’s limited scale, noting Zillow’s strong brand and incumbent advantages. Reporting framed the feature as a paid advertising partnership rather than an M&A transaction or joint venture requiring regulatory clearance.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

ServiceNow Armis Acquisition Sends Shares Lower

ServiceNow Armis Acquisition Sends Shares Lower

ServiceNow Armis acquisition reports and a KeyBanc downgrade pressured shares, raising near-term trading risk and fueling debate over M&A versus AI focus.

Luminar Bankruptcy Enables $110 Million Semiconductor Sale

Luminar Bankruptcy Enables $110 Million Semiconductor Sale

Luminar bankruptcy starts court-supervised sales and a $110M semiconductor deal; traders will watch section 363 auction, creditor backing and cash runway.

Fed Chair Candidates Warsh Leads as Hassett Faces Pushback

Fed Chair Candidates Warsh Leads as Hassett Faces Pushback

Fed chair candidates Warsh led prediction markets after Trump's shortlist, and Hassett stressed Fed independence amid pushback, shifting trader odds.

Tesla Robotaxi Testing in Austin

Tesla Robotaxi Testing in Austin

Tesla robotaxi testing in Austin began after a Dec. 14, 2025 video and CEO confirmation, prompting investor reweighting and heightened regulatory scrutiny.

Sanofi Tolebrutinib FDA Delay And PPMS Trial Failure

Sanofi Tolebrutinib FDA Delay And PPMS Trial Failure

Sanofi tolebrutinib faces a U.S. FDA delay for nrSPMS and a failed Phase 3 PPMS trial, prompting expanded access and an impairment test before Q4 results.

iRobot Bankruptcy: Picea to Take Company Private

iRobot Bankruptcy: Picea to Take Company Private

iRobot bankruptcy leaves lender Picea set to buy all equity and take the company private, prompting Nasdaq delisting and shifting trader flows.